Chemical Compound

Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1); Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, monomethanesulfonate (9CI); 1-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine methanesulfonate; CGP 57148B; Gleevac; Gleevec; Glivec; Imatinib mesilate; Imatinib mesylate; Mitinab; STI 571

CAS Registry Number 220127-57-1
返回搜索 申请报价
Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1); Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, monomethanesulfonate (9CI); 1-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine methanesulfonate; CGP 57148B; Gleevac; Gleevec; Glivec; Imatinib mesilate; Imatinib mesylate; Mitinab; STI 571 结构式
Primary record

Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1); Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, monomethanesulfonate (9CI); 1-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine methanesulfonate; CGP 57148B; Gleevac; Gleevec; Glivec; Imatinib mesilate; Imatinib mesylate; Mitinab; STI 571

库存
8,986 克
纯度
98.4 %
CAS
220127-57-1

化合物标识与属性

CAS
220127-57-1
PubChem CID
123596
SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
Canonical SMILES
CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1

名称与同义词

  • Imatinib mesylate
  • Gleevec
  • Glivec
  • 220127-57-1
  • Imatinib mesilate
  • imatinib methanesulfonate
  • Imatinib
  • Imatinib accord
  • Imatinib medac
  • sti-571
  • Genfatinib
  • Shantinib
  • Gleevac
  • imatinib oral
  • ImatinibMesylate
  • Imatinib Mesylate (STI571)
  • Imatinb Mesylate
  • Gleevec;
  • imatinib monomesylate
  • Imatinib (mesylate)
  • IMKELDI
  • Imatinib mesylate;
  • Imatinib mesylate?
  • Imatinib (as mesilate)
  • Mesylate, Imatinib
  • Gleevec (TN)
  • Glivec (TN)
  • Imatinib methane sulfonate
  • RefChem:77
  • STI571
  • Imatinib mesilate CRS
  • Imatinib(free base)?
  • Gleevec (Imatinib mesylate)
  • ST-1571 Mesylate
  • Imatinib Methansulfonate
  • Imatinib mesylate [USAN]
  • STI 571
  • Imatinib Mesylate/Glivec
  • Imatinib mesilate (JAN)
  • imatinib mesylate mesylate
  • Imatinib Mesylate Tablets
  • QTI-571
  • QTI571
  • Methanesulfonate, Imatinib
  • CGP-57148B
  • DTXSID9040502
  • Imatinib mesylate (USAN)
  • MFCD04307699
  • D0Z6KI
  • Imatinib mesylate 400 mg
  • AC1L3WY1
  • Imatinib, methanesulfonate salt
  • SCHEMBL8217
  • Imatinib Mesylate(|A form)
  • Imatinib monomethanesulfonate
  • NSC-716051
  • 8A1O1M485B
  • CGP 57148B
  • CHEMBL1642
  • IMATINIB MESYLATE 1G
  • Benzamide,monomethanesulfonate
  • 220127-57-1 (mesylate)
  • DTXCID7020502
  • Imatinib methanesulfonate salt
  • C30H35N7O4S
  • cc-159
  • CHEBI:31690
  • HSDB 7142
  • MLS001401456
  • UNII-8A1O1M485B
  • orb1307991
  • Cgp 57148
  • IMATINIB MESILATE [JAN]
  • C29H31N7O.CH4SO3
  • Imatinib (Mesylate) (Standard)
  • IMATINIB MESYLATE [HSDB]
  • IMATINIB MESYLATE 100MG
  • SCHEMBL15632914
  • SCHEMBL29370699
  • SCHEMBL29377238
  • CGP57148B
  • AOB6752
  • CGP-571
  • EX-A954
  • IMATINIB MESYLATE [VANDF]
  • SYN1046
  • CGP-57148
  • IMATINIB MESILATE [MART.]
  • NSC716051
  • YLMAHDNUQAMNNX-UHFFFAOYSA-N
  • 4-Fluoro-3-nitrophenyl isocyanate
  • BCPP000204
  • GGP-57148B
  • GLXC-05064
  • HMS2052B09
  • HMS2233D16
  • HMS3265E01
  • HMS3265E02
  • HMS3265F01
  • HMS3265F02
  • HMS3372O12
  • HMS3394B09
  • HMS3654C07
  • HMS5079E05
  • IMATINIB MESILATE [WHO-DD]
  • ACT05102
  • BCP01255
  • CGP57148
  • EBD22648
  • Imatinib for system suitability CRS
  • KS-000002AE
  • Tox21_111684
  • ABP000865
  • AC-525
  • CGP 53715
  • CI0026
  • CID123596
  • FC0015
  • HB1943
  • HY-50946R
  • NP3279
  • RS0020
  • s1026
  • Imatinib mesylate - Bio-X trade mark
  • IMATINIB METHANESULFONATE [MI]
  • AKOS015852497
  • Tox21_111684_1
  • ACN-034468
  • AN-5298
  • BCP9000776
  • CCG-101175
  • CS-0027
  • FI10812
  • IMATINIB MESYLATE [ORANGE BOOK]
  • KS-1236
  • NC00425
  • NSC 716051
  • TRA0018756
  • IMATINIB MESILATE [EP MONOGRAPH]
  • Imatinib mesylate =98.0% (by HPLC)
  • NCGC00159456-02
  • NCGC00159456-11
  • 111GE005
  • AK-44930
  • BC215795
  • BI164678
  • CPD000469175
  • HY-50946
  • LS-27113
  • SAM001246622
  • SMR000469175
  • SY013513
  • M06311
  • AB0005762
  • AB1008575
  • Imatinib mesylate, 98% - 250MG 250mg
  • ST2413118
  • TL8001825
  • TL8006192
  • AM20080900
  • CAS-220127-57-1
  • FT-0601612
  • I0936
  • NS00076459
  • SW197805-4
  • EC-000.2338
  • A-2359
  • A10468
  • D01441
  • Imatinib Mesylate (CGP-57148B, STI-571)
  • J10205
  • 152459-95-5
  • 45150-EP2270008A1
  • 45150-EP2277867A2
  • 45150-EP2280003A2
  • 45150-EP2289893A1
  • 45150-EP2292617A1
  • 45150-EP2298768A1
  • 45150-EP2305682A1
  • 45150-EP2308861A1
  • 45150-EP2308879A1
  • 45150-EP2311821A1
  • N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate
  • 127I571
  • A815828
  • A846640
  • 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate
  • I06-0363
  • Q27114666
  • Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571
  • Imatinib Mesylate/Gleevec, Glivec, CGP-57148B, STI-571
  • 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate
  • Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-, monomethanesulfonate
  • Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1)
  • Imatinib Mesylate Multi-target kinase inhibitor of abl, c-kit, and PDGFR
  • methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
  • methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
  • N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate
  • alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide
  • ;4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate
  • 4-((4-Methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide Monomethanesulfonate
  • 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin- 3-yl)-pyrimidin-2-ylamino)-phenyl]-benzamidemethanesulfonic acid salt
  • 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide methanesulfonic acid salt
  • 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]benzamide methanesulfonic acid salt
  • 4-[(4-Methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide monomethanesulphonate
  • 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate
  • 4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide mesylate
  • 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl) amino]phenyl]benzamide methanesulfonate
  • 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate
  • 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide methanesulfonate
  • 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide methanesulfonate
  • Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-monomethanesulfonate
  • Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1); Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, monomethanesulfonate (9CI); 1-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine methanesulfonate; CGP 57148B; Gleevac; Gleevec; Glivec; Imatinib mesilate; Imatinib mesylate; Mitinab; STI 571
  • Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,methanesulfonate (1:1)
  • hydron;methanesulfonate;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
  • Methanesulfonic acid--4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide (1/1)
  • methanesulfonic acid; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide
  • methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide
  • methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide
  • N-(4-methyl-3(4-(pyridin-3-yl)pyridin-2-ylamino)phenyl-4-((4-methylpiperazin-1-yl)methyl)benzamide
  • N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamidemethanesulfonate